Autopsy report · NCT03820466

Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin

“insufficient recruitment due to the pandemic situation”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 5 months before it started.
• Ran for about 2 years 2 months before it stopped.
• 68 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Dr. med. Mahir Karakas

Sponsor type

University, hospital or other

Conditions

Acute Chest Syndrome

Interventions

Aspirin; Atorvastatin; Placebo Aspirin; Placebo Atorvastatin

Participants

68

Sites

7

Countries

Germany

Trials that died the same way

• Pathology and Imaging in Kidney Allografts
  “recruitment difficulties due to impact of COVID-19 pandemic” (87% match in meaning)
• Evaluating MyPath to Enhance Reproductive Autonomy and Liberate Decision-making
  “Recruitment hindered by COVID-19 pandemic, unable to recruit participants virtually” (82% match in meaning)
• NYCHA Mindfulness-based Smoking Cessation Intervention
  “Due to the pandemic's impacts on being able to conduct the intervention for this study, unable to begin recruitment.” (81% match in meaning)
• (mo)BETTA Trial in Transwomen for Optimization of ART
  “Lack of ability to recruit due to COVID-19 pandemic” (80% match in meaning)
• Sleep, Insulin Sensitivity, and Weight in Adolescents Post-bariatric Surgery
  “COVID-19 pandemic impacted recruitment” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.